Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5d691c02-1cf6-46bf-ba09-22782dede6a3&Preview=1
Date 10/29/2008
Company Name Salient Surgical
Mailing Address One Washington Center Dover, NH 03820
Company Description TissueLink Medical provides devices that reduce surgical blood loss. Utilizing TissueLink’s saline-enhanced radio-frequency technology allows surgeons to control bleeding and improve patient outcomes.
Proceeds Purposes Salient plans to use the net proceeds to fund programs aimed at continuing to expand its sales and marketing organization and accelerating development of new advanced energy products based on its proprietary Transcollation™ technology. Salient will also use a portion of the proceeds to fund working capital requirements and amortize term debt.
M&A Terms
Venture Investor Piper Jafray Ventures
Venture Investor Arnerich Messina & Associates, Inc.
[...] apply focused radio-frequency energy and saline solution to collagen fibers in the body. Salient raised $17.9 million in Series F funding in October 2008, with backing from, Piper Jafray Ventures, Arnerich Messina [...]
$15M for Salient Surgical | OrthoSpineNews
1/8/10 6:34 pm
[...] apply focused radio-frequency energy and saline solution to collagen fibers in the body. Salient raised $17.9 million in Series F funding in October 2008, with backing from, Piper Jafray Ventures, Arnerich Messina [...]